• 'I need to understand so we can decide together': Difficult conversations about alopecia areata
• "Downy hair sign"-A clue to autoimmune disease in curly hair
• A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years
• A case of alopecia areata multiplex accompanied by chronic idiopathic thrombocytopenic purpura
• A New Method for the Follow-Up of Patients with Alopecia Areata
• A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
• A practical guide to the standardisation of hair loss photography for clinicians
• A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
• A review of TEC family kinases and their inhibitors in the treatment of alopecia areata
• Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study
• Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
• Alopecia areata following COVID-19 vaccine: a systematic review
• Alopecia areata is associated with lichen planus and lichen sclerosus in a case-control study of 4,785 patients
• Assessment of Clinician-Reported Outcome Measures for Alopecia Areata: A Systematic Scoping Review
• Association Between Natural Hair Color, Race, and Alopecia
• Association of Infantile Antibiotic Exposure and its Changes with Pediatric Alopecia Areata
• Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study
• Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis
• Atopic diseases and the risk of alopecia areata among pre-teens and teenagers in Taiwan
• Baricitinib as a treatment for myasthenia gravis: a case report
• Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial
• Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
• Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
• Cedrol in ginger (Zingiber officinale) as a promising hair growth drug: The effects of oral and external administration on hair regeneration and its mechanism
• Childhood Obesity, Weight Change, and Pediatric Immune-Mediated Skin Diseases
• Co-regulatory mechanisms and potential markers of oxidative stress-related genes in vitiligo and alopecia areata
• Coexistent frontal fibrosing alopecia with ophiasis pattern alopecia areata in a young female: A case report and review of the literature
• Commentary: Evaluating the sources and types of dietary and nutritional advice for patients with Alopecia Areata
• Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
• Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial
• Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head Assessment of Novel Approaches
• Corneal Transplant Rejection and Alopecia Areata Universalis in a Patient With Severe Atopic Dermatitis on Dupilumab
• Correction: Association of alopecia areata and ischemic heart disease and cerebrovascular disease in U.S. adults: an All of Us database study
• Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies
• Development and validation of a patient-reported outcome measure for hair loss treatment: The HAIR-Q
• Down Syndrome and Autoimmune Disease
• Dual roles of myeloid-derived suppressor cells in various diseases: a review
• Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
• Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
• Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
• Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
• Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study
• Essential Role of Macrophages in Contact Hypersensitivity-Induced Hair Regeneration
• Evaluating dermatologists' knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
• Evaluating Dermatologists' Knowledge of and Attitudes Towards Janus Kinase Inhibitor Therapy for the Treatment of Alopecia Areata
• Evaluation of Serum Inflammatory Markers and Their Relationship to Treatment Response in Alopecia Areata Patients
• Explore the genetic exposure to alopecia areata
• Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
• Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopecia Areata: A Nationwide Study
• Gamechanger bei der Therapie der Alopecia areata
• Genetic association between asthma and alopecia areata: A two-sample Mendelian randomization study
• Genetic landscape of atopic dermatitis
• Good efficacy achieved by telitacicept in treatment of systemic lupus erythematosus with alopecia areata
• Gut microbiota, skin microbiota, and alopecia areata: A Mendelian randomization study
• Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata
• Interleukin-33 links asthma to alopecia areata: Mendelian randomization and mediation analysis
• Intralesional vitamin D3 versus intralesional triamcinolone acetonoid in patchy alopecia areata: a comparative clinical and dermoscopic study
• JAK inhibition decreases the autoimmune burden in Down syndrome
• Korean Consensus Criteria for the Severity Classification of Alopecia Areata
• Large-scale whole-exome sequencing analyses identified protein-coding variants associated with immune-mediated diseases in 350,770 adults
• Lifetime incidence and healthcare disparities in alopecia areata: A UK population-based cohort study
• Linear Alopecia Areata: An Uncommon Clinical Variant. Presentation of Three Cases and Review of the Literature
• Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study
• Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
• Overcoming hurdles: Side effects with old drugs and achieving success with novel drug in alopecia areata
• Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3
• Prevalence of Self-Medication Among Patients With Common Dermatological Diseases in Saudi Arabia
• Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
• Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
• Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
• Scalp microbiome: a guide to better understanding scalp diseases and treatments
• Serum lipids may causally affect the occurrence of alopecia areata: A Mendelian randomization study
• Sex-related Variations in Comorbidities in Lichen Sclerosus: A Systematic Review and Meta-Analysis
• SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
• Structure-guided isolation of anti-neuroinflammatory sesquiterpene coumarins from Ferula sinkiangensis
• Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
• Systemic tofacitinib in paediatric alopecia areata
• Targetoid Hair Regrowth Pattern in Alopecia Areata: A Case Series
• The Association between Number of Follicular Stelae and Severity and Treatment Response of Alopecia Areata Cases: A Retrospective Study
• The causal relationship between gut microbiota and alopecia areata: a Mendelian randomization analysis
• The correlation between corona virus disease 2019 and alopecia areata: a literature review
• The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology
• The emerging role of exosomes in the treatment of hair loss
• The fate of non-scalp hair in alopecia areata universalis under baricitinib treatment: A real-world single-center experience
• The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies
• The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans
• The role of excimer light in dermatology: a review
• The role of hsa-miR-193a-5p as an important factor for control of inositol in alopecia areata
• The value of immunohistochemical expression of SOX9 and CD34 in alopecia areata
• Therapeutic effect of Nepenthes kampotiana Lecomte ethanol extract (Nk-EE) on androgenic alopecia through the inhibition of apoptosis and 5alpha-reductase activity
• Therapeutic Potential of Adipose-Derived Stem Cells and Their Secretome in Reversible Alopecias: A Systematic Review
• This Month in JAAD CaseReports: September 2024
• Tofacitinib in Pediatric Alopecia Areata Totalis and Alopecia Universalis: A Retrospective Analysis From India
• Tofacitinib in the Management of Alopecia Universalis
• Tolosa-Hunt Syndrome as the Initial Presentation of Systemic Lupus Erythematosus
• Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
• Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
• Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real-world chart review in South Korea
• Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-center retrospective study
• Zinc Status in Kurdish Adults With Hair Loss